Strategic Diagnostics Inc. (SDIX) announced an agreement to sell the assets of its Life Science business to OriGene Technologies Inc. for $16 million. Post the closing of the transaction, the company will have no remaining operations and the Board will review alternatives for the company's cash and public company status. OriGene has agreed to offer employment to a substantial majority of SDIX's employees.
The acquisition is expected to be completed during the second quarter of 2013.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.